Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML von Schütz, C, Inselmann, S, Sausslele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S, Illmer, T, Wang, Y, Lange, T, Finkernagel, F, Hehlmann, R, Huber, M, Neubauer, A, Hochhaus, A, Guilhot, J, Xavier Mahon, F, Pfirrmann, M, Burchert, A

Volltext

Respiratory failure in patients undergoing allogeneic hematopoietic SCT-a randomized trial on early non-invasive ventilation based on standard care hematology wards von Wermke, M, Schiemanck, S, Höffken, G, Ehninger, G, Bornhäuser, M, Illmer, T

Volltext

F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of t... von Beck, M., Hartwich, J., Eckstein, M., Schmidt, D., Gostian, A. O., Müller, S., Rutzner, S., Gaipl, U. S., von der Grün, J., Illmer, T., Hautmann, M. G., Klautke, G., Döscher, J., Brunner, T., Tamaskovics, B., Hartmann, A., Iro, H., Kuwert, T., Fietkau, R., Hecht, M., Semrau, S.

Volltext

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium von von Bonin, M, Stölzel, F, Goedecke, A, Richter, K, Wuschek, N, Hölig, K, Platzbecker, U, Illmer, T, Schaich, M, Schetelig, J, Kiani, A, Ordemann, R, Ehninger, G, Schmitz, M, Bornhäuser, M

Volltext

The prognostic impact of 17p ( ) deletion in 2272 adults with acute myeloid leukemia von Seifert, H, Mohr, B, Thiede, C, Oelschlägel, U, Schäkel, U, Illmer, T, Soucek, S, Ehninger, G, Schaich, M

Volltext

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients von Schaich, M., Kestel, L., Pfirrmann, M., Robel, K., Illmer, T., Kramer, M., Dill, C., Ehninger, G., Schackert, G., Krex, D.

Volltext

Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation von BORNHÄUSER, Martin, OELSCHLAEGEL, Uta, THEUSER, Catrin, MOHR, Brigitte, BRENDEL, Cornelia, FAUSER, Axel A, KLEIN, Stefan, MARTIN, Hans, EHNINGER, Gerhard, THIEDE, Christian, PLATZBECKER, Uwe, BUG, Gesine, LUTTERBECK, Karin, KIEHL, Michael G, SCHETELIG, Johannes, KIANI, Alexander, ILLMER, Thomas, SCHAICH, Markus

Volltext

P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate von ILLMER, T, SCHAICH, M, PLATZBECKER, U, FREIBERG-RICHTER, J, OELSCHLÄGEL, U, VON BONIN, M, PURSCHE, S, BERGEMANN, T, EHNINGER, G, SCHLEYER, E

Volltext

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial von Schetelig, J, Schaich, M, Schäfer-Eckart, K, Hänel, M, Aulitzky, W E, Einsele, H, Schmitz, N, Rösler, W, Stelljes, M, Baldus, C D, Ho, A D, Neubauer, A, Serve, H, Mayer, J, Berdel, W E, Mohr, B, Oelschlägel, U, Parmentier, S, Röllig, C, Kramer, M, Platzbecker, U, Illmer, T, Thiede, C, Bornhäuser, M, Ehninger, G

Volltext

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML von Schütz, C, Inselmann, S, Saussele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S, Illmer, T, Wang, Y, Lange, T, Finkernagel, F, Hehlmann, R, Huber, M, Neubauer, A, Hochhaus, A, Guilhot, J, Mahon, F X, Pfirrmann, M, Burchert, A

Volltext

Cidofovir and Foscarnet for Treatment of Human Herpesvirus 6 Encephalitis in a Neutropenic Stem Cell Transplant Recipient von Pöhlmann, Christoph, Schetelig, Johannes, Reuner, Ulrike, Bornhäuser, Martin, Illmer, Thomas, Kiani, Alexander, Ehninger, Gerhard, Jacobs, Enno, Rohayem, Jacques

Volltext

Inhibition of platelet-derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro von Fierro, F., Illmer, T., Jing, D., Schleyer, E., Ehninger, G., Boxberger, S., Bornhäuser, M.

Volltext

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myelo... von PLATZBECKER, U, THIEDE, C, SCHAICH, M, THEUSER, C, EHNINGER, G, BORNHÄUSER, M, FÜSSEL, M, GEISSLER, G, ILLMER, T, MOHR, B, HÄNEL, M, MAHLBERG, R, KRÜMPELMANN, U, WEISSINGER, F

Volltext

Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping von Thiede, C, Creutzig, E, Illmer, T, Schaich, M, Heise, V, Ehninger, G, Landt, O

Volltext

AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity von Lindner, L. H., Ostermann, H., Hiddemann, W., Kiani, A., Würfel, M., Illmer, T., Karsch, C., Platzbecker, U., Ehninger, G., Schleyer, E.

Volltext

Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Ac... von Schaich, Markus, Schlenk, Richard F, Al-Ali, Haifa K, Dohner, Hartmut, Ganser, Arnold, Heil, Gerhard, Illmer, Thomas, Krahl, Rainer, Krauter, Jurgen, Sauerland, Cristina, Buchner, Thomas, Ehninger, Gerhard

Volltext

Combining SDF-1 CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia von Fierro, F A, Brenner, S, Oelschlaegel, U, Jacobi, A, Knoth, H, Ehninger, G, Illmer, T, Bornhäuser, M

Volltext

F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan von BONIN, M, PURSCHE, S, BERGEMAN, T, LEOPOLD, T, ILLMER, T, EHNINGER, G, SCHLEYER, E, BORNHAUSER, M

Volltext

Structural chromosomal aberrations in the colon cancer cell line HCT 116 – results of investigations based on spectral karyotyping von Mohr, B., Illmer, T.

Volltext

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymp... von Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD

Volltext